Claire S. Padgett
Direttore Tecnico/Scientifico/R&S presso REGULUS THERAPEUTICS INC.
Posizioni attive di Claire S. Padgett
Società | Posizione | Inizio | Fine |
---|---|---|---|
REGULUS THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 29/11/2022 | - |
Storia della carriera di Claire S. Padgett
Precedenti posizioni note di Claire S. Padgett
Società | Posizione | Inizio | Fine |
---|---|---|---|
MIRATI THERAPEUTICS | Corporate Officer/Principal | - | 01/10/2018 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 01/02/2012 | 01/10/2018 |
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Direttore operativo | - | 28/09/2010 |
Direttore Tecnico/Scientifico/R&S | 28/09/2010 | 01/06/2011 | |
ONCOLYTICS BIOTECH INC. | Direttore Tecnico/Scientifico/R&S | 24/04/2012 | - |
Corporate Officer/Principal | 11/11/2011 | 24/04/2012 | |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formazione di Claire S. Padgett
Seton Hall University | Graduate Degree |
Rutgers State University of New Jersey | Undergraduate Degree |
Capella University LLC | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Francia | 2 |
Canada | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Chief Operating Officer | 1 |
Settori
Health Technology | 7 |
Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ONCOLYTICS BIOTECH INC. | Health Technology |
REGULUS THERAPEUTICS INC. | Health Technology |
Aziende private | 4 |
---|---|
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Conforma Therapeutics Corp.
Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Health Technology |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Claire S. Padgett
- Esperienza